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ABSTRACT
Introduction: African Americans are more likely to die from colorectal cancer (CRC) than 
any other racial/ethnic group in the United States.  Unfortunately, African Americans 
are also less likely to undergo screening for CRC than their White counterparts.  Focus 
groups methodology was used to refine educational brochures designed to increase 
CRC screening among African Americans. Methods: Two series of focus groups were 
completed, with a total of seven groups and 39 participants.   Six different brochures 
(stage-matched and culturally sensitive) designed to promote CRC screening among 
African Americans were evaluated. Results: All participants thought that the brochures 
motivated them to talk with their health care providers about screening.  Cost, pain, 
medical mistrust and fear were identified as major barriers and the brochures were 
modified to address these concerns. Conclusions: Focus groups methodology with 
African Americans can be used to inform brochures designed to increase African 
Americans CRC screening that addresses their major concerns. 
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INTRODUCTION
Low screening rates for colorectal cancer (CRC) is a major health-care challenge in the United 
States (US).  Despite evidence that CRC screening among average risk adults (e.g., those without a 
family history of CRC or personal history of  bowel disease), age 50 years and older can decrease the 
incidence and mortality rates for CRC, CRC screening rates remain low and are lower than screening 
rates for other cancers (e.g., cervical and breast) 1-5.  Generally, 91% of new cases and 94% of deaths 
from CRC occur in average risk individuals 50 years and older 6.  The recommended screening 
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guidelines for individuals at average risk include an annual fecal occult blood test (FOBT), flexible 
sigmoidoscopy (FS) every 5 years (or both FOBT and FS), double contrast barium enema every 5 
years, or colonoscopy every 10 years 6.  In 2004 (the year before this study), only about half (52.1%) of 
US adults aged 50 or older were screened using any of the above mentioned procedures within the 
recommended time interval 7.
Screening for CRC is of particular importance for African Americans because they have the 
highest incidence and mortality rates from CRC compared to any racial and ethnic group in the US 
8-10.  From 1997-2001 the CRC incidence rate among African Americans was roughly 15% higher than 
among Whites.  Mortality rates during the same period were about 40% higher in African Americans 
than in Whites 6.  African Americans are less likely to undergo screening than their White counterparts 
8.  Moreover, African Americans are at increased risk for the occurrence of and mortality from CRC if 
they reside in low socioeconomic areas 9, 11, 12. 
African Americans living in New York City (NYC) have the highest mortality rates from CRC than 
all racial and ethnic groups in NYC 13.  The NYC Department of Health and Mental Hygiene conducted 
a cross-sectional telephone study of 34 neighborhoods including descriptions of the CRC screening 
practices among adult New Yorkers aged 50 years and older.  The study concluded that the city’s 
poor and uninsured had particularly low levels of CRC screening (i.e., FOBT and endoscopic testing) 
and that Non-Hispanic Blacks and women were less likely to have a colonoscopy 5.  Colonoscopy 
has been designated as the recommended strategy for screening by the NYC Department of Health 
and Mental Hygiene because of the reported higher sensitivity of colonoscopy compared with other 
screening modalities and the local capacity in NYC to perform the procedure 5.  Additionally, studies 
have shown that screening colonoscopy in average risk populations detect more than double the 
number of adenomas when compared to flexible sigmoidoscopy and may reduce mortality and the 
incidence of CRC through early detection and the removal of precancerous polyps 8, 9.  To address 
the issue of low CRC screening rates among African Americans, this study employed focus group 
methodology as a means to inform the development of print educational materials designed to 
increase CRC screening, particularly colonoscopy, among average risk low income African Americans 
living in NYC.  
METHODS
The use of focus group methodology is the first of two phases of an ongoing study to investigate 
the impact of an educational intervention to increase CRC screening among African Americans.  The 
second phase of the study is a randomized clinical trial, investigating the impact of the educational 
brochures described here.  The goal of this paper is to report on the focus groups and to describe the 
process used to develop and improve the content and messages in CRC brochures targeting African 
Americans.  The brochures will be used in the clinical trial study phase.
Focus groups were used in the development and design of the materials in order to collect 
informal and spontaneous reactions for the target population to the issues of interest 14.  During 
the focus groups two educational material formats were compared to a standard brochure (i.e. The 
Centers for Disease Control and Prevention (CDC) Screen for Life - National Colorectal Cancer Action 
Campaign brochure entitled Colorectal Cancer Screening Saves Lives).  The first format was based on 
the Transtheoretical Model (TTM) and the second was based on Kreuter and colleagues’ strategies for 
developing culturally sensitive (C-S) educational materials 15-18.
  45
Prior to the focus groups, the research team designed six educational brochures.  Five included 
concepts from the TTM and the sixth used guidelines for creating C-S educational materials.  The 
brochures were also based on themes derived from previous studies for CRC screening and other 
studies conducted with African Americans in East Harlem, NY by the research team 1, 19, 20.
The TTM proposes that behavior change takes place in stages on a continuum rather than as a 
single, distinct event and is most successful when specific promoters (Pros) and barriers (Cons) are 
applied to the appropriate stage of change 27.  Stage-of-change refers to an individual’s readiness 
to either adopt a healthful behavior or stop an unhealthy one.  The TTM stages are termed pre-
contemplation, contemplation, preparation, action/maintenance and relapse risk; each stage has its 
own characteristics 17, 18.  
For the purpose of our study the traditional TTM stages and their corresponding characteristics 
were supplemented by early stages of readiness or adoption, from Weinstein’s Precaution Adoption 
Process Model (PAPM); thus new stages and characteristics were created.  PAPM was added as 
it incorporates several characterizations for the early pre-contemplation stage such as, being 
unaware of an issue and being unengaged by an issue 21.  Having a larger, more comprehensive pre-
contemplation stage was an important aspect of the study since we anticipated: 1) having most of 
the participants fall into pre-contemplation stages due to the low screening rates among African 
Americans in NYC, 2) the study protocol called for only participants who have never undergone an 
endoscopic procedure (which meant that there would not be an action/maintenance or relapse risk 
stage), and 3) we wanted to better understand the earlier pre-contemplation stages, again because 
of low CRC screening rates among African Americans 5, 8.  Five stages, each with its own characteristics 
and each determining a participant’s stage-of-change or readiness to undergo an endoscopic 
procedure were defined as shown in Table 1.  
Standard & Staged-Matched (S-M) Brochures
The Centers for Disease Control and Prevention (CDC) Screen for Life - National Colorectal 
Cancer Action Campaign brochure entitled Colorectal Cancer Screening Saves Lives was used as a 
guide for the content and layout of the S-M brochures.  The CDC brochure was used as the standard 
control brochure because of its broad appeal to all racial and ethnic groups and its mainstream 
subject matter.  The S-M brochures were designed to look similar to the CDC brochure as well as 
deliver standard messages.  Both have sections entitled “What is Colorectal Cancer?” and “Who gets 
Colorectal Cancer?”  Both brochures also discuss different types of CRC screening modalities, signs 
and symptoms of CRC and the cost of testing procedures.
The S-M brochures also focus on the critical issues of each stage (see Table 1). We addressed 
each stage by first creating stage specific intervention strategies to help guide the direction of the 
brochures by showing what actions should be taken at each stage.  The stage specific intervention 
strategies are based on a model developed by TTM researchers (e.g. 22) and our data from prior 
studies using Pros and Cons items.
The front panel of each of the five S-M brochures displays specific messages that speak directly to 
each stage. The wording from the stage characterizations was used.  For instance, the contemplation 
stage characterization is “The person is considering undergoing colonoscopy screening in the next 
year.”  Thus, the front panel message reads “Good for you, you’re thinking about colorectal cancer 
screening! Here’s what you should know!”  Furthermore, Pros and Cons items were also matched 
to each stage and appropriate statements were incorporated into the brochures.  The items were 
selected based on data analysis from our prior research 1, 19 with African Americans who were 
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Table 1. Stages of Change Characteristics and Intervention Strategies
Stage Stage 
Characterization
Stage Specific 
Intervention 
Strategies
Front Panel 
Messages
Brochure Statements 
Pre-
contemplation 
1
The person is 
unaware of CRC 
risk. 
Provide information 
on the benefits of 
screening.  Provide 
information on 
the procedure.  
Emphasize risk.  
Appeal to emotions.
“This brochure 
was created for 
you and others 
like you who have 
NEVER heard of a 
colonoscopy.”
“Think about colorectal 
cancer screening/
colonoscopy.  Do it for 
your health and the well 
being of your family.” 
“You’ll feel better about 
yourself.”
Pre-
contemplation 
2
The person is 
aware of the CRC 
risk, but has never 
considered having 
a colonoscopy.
Provide information 
on the benefits of 
screening. Provide 
information on the 
procedure.  Review 
procedure.
“This brochure 
was created for 
you and others 
like you who 
have NEVER 
considered 
having a 
colonoscopy.”
“Think about colorectal 
cancer screening/
colonoscopy.  Do it for 
your health and the well 
being of your family.” 
“You’ll feel better about 
yourself.”
Pre-
contemplation 
3
The person is 
aware of the 
CRC risk and has 
considered having 
a colonoscopy but 
decided against it. 
Tip the decisional 
balance to LESS 
cons and MORE 
Pros.  Address the 
common cons and 
why person decided 
against procedure.  
Show some 
benefits/common 
pros associated 
with screening.  
This brochure 
was created for 
you and others 
like you who 
say they do not 
want to have a 
colonoscopy.”
“Re-think your decision 
about colorectal cancer 
screening/colonoscopy.”  
“Do it for your health and 
the well-being of your 
family.” “You’ll feel better 
about yourself.”
Contemplation The person is 
considering 
undergoing 
screening in the 
next year.
Emphasize benefits.  
Address pros (why 
to get procedure) 
and than some 
common cons – 
misconceptions. 
“Good for you, 
you’re thinking 
about colorectal 
cancer screening! 
Here’s what you 
should know!”
“It’s good you’re thinking 
about colorectal cancer 
screening/colonoscopy.” 
“Make that appointment 
for your health and the 
well-being of your family.” 
“You’ll feel better about 
yourself.”
Preparation The person has 
an appointment 
scheduled for 
screening.
Use strategies 
to enhance 
commitment. 
“Good for 
you! You’ve 
scheduled your 
colonoscopy. 
Here’s what you 
should know!”
“Congratulations 
on scheduling your 
colorectal cancer 
screening/colonoscopy 
appointment.”  “It’s so 
important to your health 
and the well-being of your 
family.” “You’ll feel better 
about yourself.”
Note.  Stage Characteristics have been published previously by Christie et al., In press 27.
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adherent and non-adherent to CRC screening.  For example, using SPSS (version 15.0), the frequency 
distribution illustrated that individuals who have not had endoscopic screening were more likely to 
agree with the Cons item, “Colorectal cancer tests are risky, if colorectal cancer tests find a problem, 
it is too late to do anything about it.”  Additionally, those who have had endoscopic screening were 
more likely to agree with the Pros item, “Having regular colorectal cancer tests would give me peace 
of mind about my health.”  Therefore, to address the Cons items, the Pre-contemplation 1-3 and 
Contemplation brochures all answer the questions “Are screening tests safe?” and “What if something 
is found, will it be too late to do something about it?”  The brochures also include statements 
emphasizing the health benefits to getting screened and that one would feel good about oneself if 
they got tested in order to speak to the Pros items.
Lastly, the S-M brochures included general concepts, such as asymptomatic disease (i.e., not 
showing or producing indications of a disease or other medical condition), doctor recommendation, 
fear, pain, and feeling inconvenienced by screening tests.  These themes were incorporated into 
the S-M brochures as previous research by the study team on cancer knowledge and barriers and 
promoters of cancer screening (i.e., breast, prostate, and colorectal) with African Americans in 
East Harlem indicated that they were very important issues.  For example, the subject of pain was 
addressed by answering the question “Are screening tests (colonoscopy) painful?”  
Culturally Sensitive (C-S) Brochure
Kreuter and colleague’s strategies for developing culturally sensitive educational materials were 
used to design the C-S brochure.  The strategies are as follows: 1) Peripheral strategy; this approach 
emphasizes the appearance of cultural appropriateness by presenting materials in ways that are 
most likely to appeal to a particular group, including visual elements, such as colors, layout design, 
and images; 2) Evidential strategy; which focuses on the relevance of a health issue to a group by 
showing its impact on that group through data, including rates of incidence, prevalence, mortality 
or disparity; 3) Linguistic strategy focuses on using the preferred language of a specific group; 4) 
Constituent involving strategy draws directly upon the experience and expertise of members of the 
target population, and 5) Sociocultural strategy addresses health-related issues in the context of 
broader social and cultural values and characteristics of a group 16.
Regarding peripheral strategy, visual elements were used, such as images of African American 
men and women and the use of warm earth tone colors in a kente cloth pattern.  Additionally, 
we used a declarative statement on the brochure cover title; “What Black Men and Women need 
to know about Colorectal Cancer Screening.”  For the evidential strategy, data on the relevance of 
CRC to African Americans was illustrated in a paragraph headlined, “Black adults are more likely 
to die from colorectal cancer compared to any other racial group.”  We talked directly about how 
African Americans are affected by CRC, presenting statistical data (i.e., mortality rates).  Lastly, a CRC 
survivor’s story that was spiritually based, entitled, “I beat colorectal cancer” incorporated strategies 3 
and 4 by drawing directly upon the experiences of African Americans and using language specific to 
African Americans. 
Like the S-M brochures, the C-S brochure also addresses issues such as cost, fear, pain, and feeling 
inconvenienced by screening tests.  However, when dealing with these issues the brochure sections 
are worded differently in order to reflect the different brochures and methodology.  The sociocultural 
strategy guided the wording in the C-S brochure.  For example, to talk about the inconvenience 
of testing, the S-M brochure section targets the individual and is entitled “Don’t put off getting 
screened” and in the C-S brochure the section appeals to a cultural value and is entitled “Take care of 
yourself so you can take care of your family.”
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Finally, the constructs of medical mistrust and fatalism were integrated into the C-S brochure.  
These were found to be significant to the African Americans who participated in past research 
with the research team and in our focus groups 23.  Fatalism is the belief that death is inevitable 
when cancer is present.  Medical mistrust is defined as a tendency to distrust medical systems and 
personnel believed to represent the dominant culture (e.g., Thompson et al 2004 23).  To address 
fatalism a section of the brochure reads, “It seems to me there is nothing you can really do about 
getting cancer.”  The section then goes on to discuss the importance of early removal of pre-
cancerous polyps.  In order to speak to medical mistrust, there is a section “Doctors are always telling 
me to get one test or another.  Is colorectal cancer screening really necessary?”  Here we inform our 
target population that we are aware of their suspicions, nevertheless it is important to be informed 
about how CRC screening saves lives.
Focus Groups
Two series of focus groups were completed, with a total of 7 groups and 39 participants.  The 
participant’s age ranged from 55 to 78 years with a mean age of 68.21 (SD= 5.69).  Sixty-two percent 
were female and a majority (66.7%) reported an annual income of $14,999 or less.  Forty six percent 
had less than a High School (or a GED) degree.  The majority had health insurance (90.5%) and noted 
having a primary care physician (76.9%).
All of the focus groups were held in East Harlem, NY between January 2005 and May 2005.  
An African American Project Coordinator served as facilitator at each focus group.  Six different 
CRC educational brochures (Pre-Contemplation 1, Pre-Contemplation 2, Pre-Contemplation 3, 
Contemplation, Preparation, and Culturally Sensitive) designed by the research team were compared 
to the standard CDC brochure entitled Colorectal Cancer Screening Saves Lives, to evaluate the 
acceptability, understanding, and appropriateness of our materials.
The focus group participants were recruited from neighborhood community and senior 
centers and the East Harlem community at large.  Mount Sinai School of Medicine’s IRB approved 
recruitment fliers, which had tear off sheets with our telephone number on it, and were posted 
at community sites and health clinics.  The fliers had a picture of an African American man and 
woman.  Additionally, an advertisement was placed in a local newspaper, which targets the African 
American community.  The inclusion criteria for the focus groups were as follows: male or female, self-
identified as Black or African American, 51 years of age or older (to give participants at least one year 
after their 50th birthday to undergo screening), at average risk for CRC, must not have undergone 
an endoscopic screening exam and must have telephone service.  HIPAA and IRB consent forms 
were completed at the beginning of each focus group.  Participants were reimbursed $25 for their 
participation. 
The focus group questions were open-ended and asked about participant’s general knowledge 
of CRC screening, their satisfaction with the educational materials, as well as the cultural relevance 
and coherence of the brochures. Additionally, we asked for suggestions on ways to improve the 
educational materials. The questions are listed in Table 2.
Each focus group lasted two hours; was audio taped and transcribed to facilitate qualitative 
analyses.  The purpose of the first series (Set 1) of four focus groups was to refine the educational 
brochures that were designed by the team.  We wanted feedback on the brochure content, layout, 
color and coherence.  Each group viewed the brochures and compared them to the standard CDC 
brochure.  Changes were made to the brochures after the first series of focus groups.  The second 
series (Set 2) of three focus groups were conducted to gather further feedback on the brochures and 
to consider the content changes that were already made to the brochures.  These participants also 
compared our brochures to the standard brochure.
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Table 2. Focus Group Questions
Participants Prior Knowledge 
• Before today, what did you know about colorectal cancer?
• Before today, what did you know about colorectal cancer screening?
Evaluation of Brochures 
Appearance 
• After reviewing the brochures on colorectal cancer and colorectal cancer screenings, what 
thoughts come to mind?
• What do you think about the pictures/graphics/colors used in the brochure?
Ease of Comprehension & Readability 
• Was the information presented in a clear and understandable manner? (What do you think 
about it?)
• Is there anything you would change about the information? What would you keep the same?
Knowledge Content
• Do you think this information in the brochures are useful/applicable to you? Why or why not?
• How could we make this information more useful/applicable to you?
Attitudes & Perception 
• What impact does this information have on your view of colorectal cancer and screening? 
• Has/have your understanding/feelings about colorectal cancer and screenings changed?
• Do you think people similar to you worry about getting colorectal cancer? (If so, do the 
brochures address this? And how do you think it should be described in the brochures?).
Testing & Decision Making 
• Would you seek colorectal cancer screening based on the information presented? Why or Why 
not?
• What information would help you decide whether or not to be screened/tested?
• What are the benefits of getting screened/tested? What are the disadvantages?
• Do you think we should add anything about abnormal findings [to the brochures]?  For 
example, if the doctor finds something wrong, what you should do?
Group Specific Issues related to CRC 
• Are there things that may be important to Black men/women in general in making the decision 
to be screened for colorectal cancer?
• What do you think keeps Black men/women from getting screened? 
• What myths exist about colorectal cancer and screening?
RESULTS
For the first series of focus groups, 4 sessions were completed with a total of 21 participants.  
There were two all female groups, one all male group, and one mixed gender group.  Sixty-two 
percent (N=13) were female and 38% (N=8) were male.  Their ages ranged from 57-78 years.  The 
second series of focus groups included 3 groups with a total of 18 participants.  There was one 
all male group (N=6), one all female group (N=5) and one mixed gender group (N=7).  Some of 
the participants (N=11) had also attended focus group Set 1 and the remainder (N=7) were new 
participants. 
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All of the participants reported coherency and understandability of the S-M, C-S, and standard 
brochures.  They thought that all the brochures were informative, however, when compared to the 
standard brochure, participants thought the S-M brochures had more details and regarding the C-S 
brochure a participant remarked as follows, “They both are informative, but I’m drawn to the colors in 
this [C-S] brochure.”  Additionally, the participants reported that the various font sizes and styles were 
easy for them to see and that after reading the brochures they felt more encouraged to get tested 
and/or talk with their health care providers about CRC screening.  
The first set of focus group participants recommended revisions to the brochures.  They thought 
that both the S-M and C-S brochures needed more information about the cost and how to pay for 
the colonoscopy procedure.  Accordingly, we added information for governmental and national 
cancer organizations that may provide assistance to the redesigned brochures.  Participants also 
thought that the picture of the human gastrointestinal system on the standard brochure was larger 
than those pictured in the other study brochures and recommended that we enlarge our picture.  
Revisions were made where space permitted. 
Regarding the S-M brochures, Set 1 focus group participants felt that all the brochures looked 
the same except for their colors.  This was an important observation because although we wanted 
the brochures to look similar we also wanted them to be distinguishable, which was one reason 
why the stage characterization wording was placed on the front panels.  In the redesign we focused 
on content placement on the inside of the brochures as a way to distinguish the messages at each 
stage.  The brochures immediately address the barriers that were found at the different stages.  For 
example, the Pre-Contemplation 3 stage characterization is that “a person has considered having a 
colonoscopy but decided against it.”  A major barrier for patients at this stage is fear of the procedure 
and the results.  On the first inside panel, we discuss doctor recommendation with the heading 
“Here’s what doctors say about screening,” discuss fear with the caption “Don’t let fear stop you” and 
we ask patients to reconsider getting tested by arguing the benefits of getting screened.  
Two groups from the first set of focus groups felt that the brochures should address the issue 
of embarrassment, while the other two groups didn’t think it needed to be discussed.  Here is a 
response from a male participant from a group that did not think embarrassment should be included 
in the brochures: “When you reach a certain age, there is no more embarrassment, you need to 
stay healthy.”  Moreover, here’s the perspective of a male participant that thought embarrassment 
should be included: “Men are very conscious of tests in the rectum.”  The research team addressed 
embarrassment in the revision of the brochures as it is documented in the literature that 
embarrassment is a barrier to CRC screening 24, 25. 
Participants were asked to respond to the question – “Do you think we should add anything 
about abnormal findings [to the brochures]?  For example, if the doctor finds something wrong, what 
you should do?”  There were mixed opinions on the topic; some participants’ thought it was a good 
idea while others did not.  The following are some responses:
“[Yes] it should say something like seek treatment/go for treatment if something is found 
because people get scared and may not do anything.” and “Yes, you are briefed before you meet 
with the doctor – you are more prepared when you talk with the doctor.”  Other responses included: 
“[No] I don’t think so, because brochures can be scary and we should talk with our doctors after 
the procedure to find out what’s going on.” and “No, it will scare people.”  From the study team’s 
perspective it was thought that the brochures in their current format were not the appropriate 
condition to address issues such as advanced cancer or colostomies, therefore abnormal findings 
were not included in the brochures.  All of the brochures do, however, have a cartoon picture of a 
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colon with a polyp on it, which was thought more suitable for a brochure targeting average risk 
individuals who had never undergone a colonoscopy.
The second set of focus group participants confirmed the brochure revisions that were made after 
the first set of focus groups.  They too, thought the brochures were very informative and encouraged 
them to talk with their health care providers about CRC screening.  Furthermore, they thought the 
brochures addressed many of their concerns about the colonoscopy procedure, including cost, pain 
and fear.  
Fear and pain of the colonoscopy procedure were constant themes throughout both sets of focus 
groups.  When participants were asked, “Before today, what did you know about colorectal cancer?” 
and “Before today, what did you know about colorectal cancer screening?” the concerns of fear and 
pain were immediately raised.  The participants had very strong feelings about these issues.  The 
following are examples of what participants said regarding these concerns: “[Colorectal cancer] is 
very scary-it’s a dangerous disease.”  “[Screening] is painful, so I try to avoid it; I want to know if there 
is an easier way to get screened.” “I’ve heard it’s [screening] very painful, they put a tube in your 
rectum.”  Issues of fear and pain were addressed in all of the S-M and C-S educational brochures. 
All of the participants from both sets of focus groups who viewed the C-S brochure felt that it 
taught them more about their risk as African Americans for developing CRC.  Many stated that the 
“survivor’s story” touched them and would motivate African Americans to get screened.  Lastly, the 
C-S educational brochure was initially intended to be a four sheet educational booklet, however; the 
participants thought it was too long, thus it was shortened to two-pages.  
The subject of medical mistrust was broached in a majority (six out of seven) of the focus groups.  
This issue was specifically addressed in the C-S brochure by speaking directly to the issue with 
the following statement and question “Doctors are always telling me to get one test or another. Is 
colorectal cancer screening really necessary?”  As one of the male focus group participants said: 
“Black men were used as guinea pigs with syphilis, so when we have a colonoscopy or anything 
like that (things concerning cancer, a virus or bacteria) we have major concerns. Are we going to be 
used as guinea pigs?  This is still embedded in our minds.  It makes us very fearful.  In reality it’s not 
happening but we have it in our minds.”  
Examples of the resulting, final brochures are illustrated in Figure 1 (S-M, Contemplation) and 
Figure 2 (C-S). 
  It’s important to again point out that both the S-M and C-S brochures included mainstream subject 
matter that was also found in the standard CDC brochure.  However, through use of the TTM stages of 
change, the culturally sensitive model for educational materials development and data from previous 
research, the study brochures were more distinct at addressing barriers to CRC screening specifically 
for African Americans and they appealed more to the focus group participants.  When comparing the 
S-M Preparation brochure to the standard brochure participants said the following: “If they were side 
by side in a rack I would pick this one [S-M brochure] as opposed to the other [standard] because of 
the colors, and the way it’s formulated, it grabs my attention.”  “It also rewards me and congratulates 
me for even thinking about looking at this.”  “It is a feel good with the colors and another feel good 
because it says Good for you.”  “It makes me want to look inside.”  Furthermore, a group comparing 
the C-S brochure to the standard brochure made the following comments: “the [standard brochure] 
doesn’t seem geared toward African-Americans,” “the huge diagram [colon] is scary” and “It has a lot 
of good information in it.”  Participants also pointed out regarding the C-S brochure “the colors are 
good and I like the kente cloth pattern.”  “The size [font] is good,”  “the diagram isn’t scary,”  “the Q & A 
section is good” and “it’s excellent.”
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Figure 1. S-M, Contemplation)
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Figure 2. C-S
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DISCUSSION
This study employed focus groups as a method to inform the development of print educational 
materials designed to increase CRC screening among African Americans at average risk for CRC.  
The focus groups provided important information about low-income urban African Americans’ 
knowledge of CRC and CRC screening as well as identified attitudinal, interpersonal, and practical 
factors that may influence their screening behaviors.  In addition, the focus groups also provided us 
with detailed suggestions for refinement of the educational materials to make them more relevant 
and motivational for African Americans.  Each of these points is discussed in detail below. 
Regarding knowledge of CRC and CRC screening, an overwhelming number of participants had 
misconceptions about the colonoscopy procedure, although 59% had heard of a colonoscopy.  These 
misconceptions included believing that colonoscopy was a surgical procedure requiring an overnight 
stay in the hospital and thinking that developing CRC was linked to having diabetes. Additionally, 
over half of the participants were unaware of their personal risk of developing CRC.  These findings 
suggest that more education and increased awareness of CRC and CRC screening modalities are 
needed in this community. The results also suggested that fear, pain, embarrassment, and medical 
mistrust are major themes associated with CRC screening for African Americans.  
Each of these themes had salience for the participants; however, fear, pain, and medical mistrust 
were cited most often, which suggest that they may be key barriers to CRC screening among African 
Americans and need to be addressed in intervention materials designed to increase screening in this 
population. 
In addition to attitudinal and interpersonal factors, cost and concerns about income and 
insurance coverage were also identified as barriers to screening. This result suggests that in addition 
to information on attitudinal barriers and the importance of communication with one’s doctor, 
educational materials need to also address practical barriers such as cost and provide clear guidance 
on how to obtain free or low-cost screening and/or information about Medicare and insurance 
policies. 
While this study has many strengths such as its focus on an underserved population for which 
colonoscopy may be critically important, there are study limitations. First, our focus groups were 
conducted with a patient population and did not include physicians. Conducting focus groups with 
physicians would have given us the opportunity to learn more about the factors that encourage and/
or discourage physicians to recommend and encourage CRC screening and may be an important 
focus in future research. Our reasons for concentrating on educational materials for patients include 
the fact that they are easily distributed and commonly used26. Moreover, there is a growing trend 
towards shifting the responsibility of organizing health care to the patient. Further, health promotion 
theories such as the Transtheoretical Model (TTM) propose that individuals bear some responsibility 
for their healthy or unhealthy behaviors. Although we focused on individuals, we recognize that CRC 
screening is a complex problem that involves the health care system, as well as health care providers, 
and the patients. In future research it would be important to investigate health care system barriers 
such as the lack of a computer CRC screening reminder system as well as patient and physician 
barriers.
The second limitation is that the inter-relations of the factors that were associated with CRC 
screening in this population were not addressed.  In future research it would be important to 
address the relations of these factors such as the relation of medical mistrust and, patient doctor 
communication.  Such relations may be investigated by in-depth interviews addressing these 
concepts.  
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A final limitation is the focus on urban, English speaking African Americans.  The barriers and 
promoters of CRC screening for African Americans needs to be addressed in additional geographic 
locations as well as in other languages to more adequately represent the diversity of this population. 
CONCLUSIONS
Despite the study limitations, this study provides support for the use of focus group methodology 
to inform the development of educational materials to increase CRC screening among African 
Americans.  The focus groups provided valuable information about barriers to screening among 
low income, urban African Americans including cost, pain, fear, medical mistrust and low physician 
recommendation, suggesting that these are important issues to address when designing 
interventions to increase CRC screening for this population.  The focus groups also informed the 
brochures’ content, layout and color suggesting that focus groups are a useful methodology 
for ensuring that interventions are appealing and relevant to the target population.  Thus, the 
educational brochures were developed to increase colonoscopy among African American with the 
goal to increase the prevention and early detection of CRC and reduce health disparities with regard 
to CRC.  We are currently investigating the impact of the materials we developed on CRC screening in 
a randomized clinical trial with African Americans.
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